A Porcine Model for Repair of Long Bone Non-Union Defects Using Three-Dimensionally Printed Scaffolds
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2021, Vol 2, Issue 2
Abstract
Background: Approximately 5-10% of bone injuries in the United States result in non-union, costing an estimated $10.4-26.1 billion annually for treatment. While several orthopedic strategies to address non-unions in long bones are available, all have drawbacks and risks of complications. A possible alternative is the recent advances in tissue engineering treatments that are improvements over current treatment options. Methods and Findings: We have developed a porcine long bone segmental defect model for testing osseous non-union repair using 3D-printed biodegradable scaffolds. We generated a 3.5 cm mid-diaphyseal defect in the right radius of a six-month-old pig. A Polycaprolactone (PCL) scaffold implant designed from radius Computed Tomography (CT) scans and produced using solid form fabrication was implanted into the defect and stabilized with a stainless-steel plate. The animal could stand and place weight on the limb at six hours post-surgery and ambulating without a noticeable limp by four weeks. CT imaging post-surgery show bone fill in the defect space by two weeks, significant defect closure by eight weeks and complete union by 24 weeks. This healing has taken place on a PCL scaffold with no other treatments in conjunction with the implant. Conclusion: The porcine radius segmental defect model provides a viable platform for testing printed scaffolds and bioengineered composite scaffold constructs for the efficacy of healing segmental defects and other forms of non-union in long bones.
Authors and Affiliations
Derek J Milner, Sierra A Long, Colleen L Flanagan, Scott J Hollister, Robert Gurtler, Robert Bane, Jerrad Zimmerman, Jo Ann Cameron, Santiago D Gutierrez-Nibeyro, Matthew B Wheeler
Keywords
Related Articles
- EP ID EP698856
- DOI http://dx.doi.org/10.46889/JRMBR.2021.2203
- Views 56
- Downloads 0
Patient Perspectives on Use of Stem Cells to Treat Osteoporosis
Osteoporosis is a systemic skeletal disease leading to increased risk of fragility fractures. These fractures lead to significant patient morbidity, increased mortality and substantial health and social care costs. Th...
A Gout Flare Caused by the Administration of Platelet Rich Plasma: A Clinical Case
The therapy with Platelet Rich Plasma (PRP) administered in degenerated or injured musculoskeletal tissues is a new and promising regenerative treatment option. Traditionally, it is considered that as PRP represents an a...
The Use of Stem Cell Therapy in the Treatment of Autism Spectrum Disorder
Research on the use of stem cell therapy in regenerative medicine has shown great potential in the treatment of neurological disorders. Specifically, mesenchymal stem cells, adult stem cells from the umbilical cord and e...
Local Anesthetics Can Affect the Efficacy of Telomerase-Positive Stem Cells
Early clinical studies with telomerase-positive stem cells demonstrated no response when these stem cells were mixed with lidocaine prior to clinical treatments in multiple individuals. Their stem cells demonstrated a...
Adipose-Derived Stem Cells: Isolation and Utilization within Regenerative Medicine and Cosmetic Procedures
Adipose-derived stem cells are a promising tool for the future of reconstructive surgeries, regenerative therapies and cosmetic procedures. Their ability to be safely, efficiently and cost-effectively isolated from extra...